Table 3.
Histological findings of patients with nonalcoholic fatty liver disease, divided according to nonalcoholic fatty liver disease without type 2 diabetes mellitus and nonalcoholic fatty liver disease with type 2 diabetes mellitus n (%)
| Parameter | All patients (n = 235) | NAFLD (without T2DM) (n = 158) | NAFLD (with T2DM) (n = 77) | P value |
| NAS score (mean ± SD) | 3.2 ± 1.7 | 3.0 ± 1.6 | 3.5 ± 1.7 | 0.03 |
| Fibrosis score (mean ± SD) | 0.75 ± 1.1 | 0.52 ± 0.9 | 1.2 ± 1.3 | < 0.01 |
| Fibrosis score | < 0.01 | |||
| < 2 | 191 (81.3) | 139 (88.0) | 52 (67.5) | |
| ≥ 2 | 44 (18.7) | 19 (12.0) | 25 (32.5) | |
| NAS score | 0.12 | |||
| < 5 | 179 (76.2) | 125 (79.1) | 54 (70.1) | |
| ≥ 5 | 56 (23.8) | 33 (20.9) | 23 (29.9) | |
| NAS score | 0.11 | |||
| < 3 | 90 (38.3) | 66 (41.7) | 24 (31.2) | |
| ≥ 3 | 145 (61.7) | 92 (58.3) | 53 (68.8) | |
| Steatosis | 0.1 | |||
| < 2 | 97 (41.3) | 71 (44.9) | 26 (33.8) | |
| ≥ 2 | 138 (58.7) | 87 (55.1) | 51 (66.2) | |
| Ballooning | < 0.01 | |||
| < 2 | 193 (82.1) | 137 (86.7) | 56 (72.7) | |
| 2 | 42 (17.9) | 21 (13.3) | 21 (27.3) | |
| Inflammation | 0.4 | |||
| < 2 | 218 (92.7) | 148 (93.7) | 70 (90.9) | |
| ≥ 2 | 17 (7.3) | 10 (6.3) | 7 (9.1) | |
| Mallory bodies | 50 (21.3) | 28 (17.7) | 22 (28.6) | 0.06 |
NAFLD: Nonalcoholic fatty liver disease; NAS: NAFLD activity score; T2DM: Type 2 diabetes mellitus.